New Delhi: The Drug Controller General of India (DCGI) on Wednesday approved the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine developed by Serum Institute of India, Pune.
The vaccine will be used to create active immunization against invasive disease and pneumonia caused by ‘Streptococcus pneumonia’ among infants. It is administered in an intramuscular manner.
Three phases of clinical trials were conducted in India as well as in Africa’s Gambia.
The institute has been granted permission to manufacture the Pneumococcal Polysaccharide Conjugate Vaccine domestically. This is the first indigenously developed vaccine in the field of pneumonia.
Earlier, this vaccine had to be imported.
Also Read:- Corona Vaccine Update: UK’s Imperial College To Begin Phase 1 Human Trials On June 15
Bargarh: A new artist will be selected to play the mythological character King Kansa during…
Mumbai: Suhana Khan will be making her Bollywood debut with ‘King’ along with her superstar…
New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…
New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…
Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…